摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(Hydroxymethyl)-6-prop-2-enoxyoxane-3,4,5-triol | 7464-56-4

中文名称
——
中文别名
——
英文名称
2-(Hydroxymethyl)-6-prop-2-enoxyoxane-3,4,5-triol
英文别名
——
2-(Hydroxymethyl)-6-prop-2-enoxyoxane-3,4,5-triol化学式
CAS
7464-56-4
化学式
C9H16O6
mdl
MFCD00517491
分子量
220.222
InChiKey
XJNKZTHFPGIJNS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    138-141°C
  • 沸点:
    415.0±45.0 °C(Predicted)
  • 密度:
    1.37±0.1 g/cm3(Predicted)
  • 溶解度:
    DMSO(少许)、甲醇(少许)、水(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.6
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.777
  • 拓扑面积:
    99.4
  • 氢给体数:
    4
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2932999099
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P330,P363,P501
  • 危险性描述:
    H302,H312,H332

SDS

SDS:2f270d514527b25c077e4014f7c551fc
查看

文献信息

  • GLYCOSYLATED CHLORAMBUCIL ANALOGS AND USES THEREOF
    申请人:Thorson Jon S.
    公开号:US20120094946A1
    公开(公告)日:2012-04-19
    A library of glycosylated chlorambucil analogs which are useful as anti-tumor and/or anti-metastatic agents is disclosed. The glycosylated chlorambucil analogs have the general formula wherein represents a reducing sugar moiety.
    揭示了一种作为抗肿瘤和/或抗转移药物有用的葡萄糖基氯氨丁醇类似物的图书馆。这些葡萄糖基氯氨丁醇类似物具有一般公式,其中表示还原糖基团。
  • OLEFIN METATHESIS REACTIONS OF AMINO ACIDS, PEPTIDES AND PROTEINS CONTAINING ALLYL SULFIDE GROUPS
    申请人:Lin Yuya Angel
    公开号:US20120178913A1
    公开(公告)日:2012-07-12
    A method for the modification of an amino acid, protein or peptide is disclosed. The method comprises reacting a carbon-carbon double bond-containing compound with an amino acid, a protein or a peptide containing an allyl sulfide group in the presence of a catalyst which promotes olefin metathesis, to form a modified amino acid, protein or peptide. Preferred carbon-carbon double bond-containing compounds include carbohydrates.
    揭示了一种用于修饰氨基酸、蛋白质或肽的方法。该方法包括在促进烯烃交换反应的催化剂存在下,将含有碳-碳双键的化合物与含有烯丙基硫醚基团的氨基酸、蛋白质或肽反应,以形成修饰后的氨基酸、蛋白质或肽。首选的碳-碳双键含有化合物包括碳水化合物。
  • [EN] METHODS FOR SYNTHESIZING MOLYBDOPTERIN PRECURSOR Z DERIVATIVES<br/>[FR] PROCÉDÉS DE SYNTHÈSE DE DÉRIVÉS Z DE PRÉCURSEUR DE MOLYBDOPTÉRINE
    申请人:ALEXION PHARMA INC
    公开号:WO2012112922A1
    公开(公告)日:2012-08-23
    Provided herein are synthetic methods for preparing a compound of formula (I): Also provided herein are synthetic methods for preparing a compound of formula (XIII): The disclosure also provides useful intermediates, derivatives, prodrugs, and pharmaceutically acceptable salts, solvates and hydrates of the formula (I) and formula (XIII) compounds. These compounds are useful for treating diseases associated with molybdenum cofactor deficiency.
    本文提供了制备式(I)化合物的合成方法。本文还提供了制备式(XIII)化合物的合成方法。本公开还提供了式(I)和式(XIII)化合物的有用中间体、衍生物、前药和药用可接受的盐、溶剂合物和水合物。这些化合物可用于治疗与钼辅因子缺乏相关的疾病。
  • COMPOUND HAVING TUMOR-RESIDENT PROPERTY
    申请人:OHTA Keisuke
    公开号:US20100202971A1
    公开(公告)日:2010-08-12
    The problem to be solved of the present invention is to provide a novel compound which specifically resides in a tumor, a method for allowing it to reside in a tumor, and a method for detecting, diagnosing, and treating tumor with use thereof. Means for solving the problem is a compound represented by chemical formula (I) wherein R is an anionic group binding to hydrogen, R 1 is OH, OCOH, OCO(CH 2 ) h CH 3 , or an acting group, h being an integer of 0 or more, R 2 is H, OH, OCOH, OCO(CH 2 ) i CH 3 , or an acting group, i being an integer of 0 or more, R 3 is OH, SO 3 H, or an acting group, R 4 is OH, SO 3 H, or an acting group, and R 5 is OH, SO 3 H, or an acting group, at least one of R 1 , R 2 , R 3 , R 4 , and R 5 containing an acting group, or pharmaceutically acceptable salts thereof.
    本发明要解决的问题是提供一种新型化合物,该化合物专门存在于肿瘤中,以及使其存在于肿瘤中的方法和使用其进行肿瘤检测、诊断和治疗的方法。解决问题的方法是提供一种由化学式(I)表示的化合物,其中R是与氢结合的负离子基团,R1是OH、OCOH、OCO(CH2)hCH3或作用基团,h是0或更多的整数,R2是H、OH、OCOH、OCO(CH2)iCH3或作用基团,i是0或更多的整数,R3是OH、SO3H或作用基团,R4是OH、SO3H或作用基团,R5是OH、SO3H或作用基团,其中R1、R2、R3、R4和R5中至少有一个含有作用基团,或其药学上可接受的盐。
  • METHODS FOR SYNTHESIZING MOLYBDOPTERIN PRECURSOR Z DERIVATIVES
    申请人:Alexion Pharma International SÀRL
    公开号:EP2675278A1
    公开(公告)日:2013-12-25
查看更多